New England Research & Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
18,461
-1,930
-9% -$182K 0.52% 62
2026
Q1
$2.41M Buy
20,391
+344
+2% +$42.5K 1.02% 28
2025
Q4
$2.52M Sell
20,047
-3,563
-15% -$465K 1.1% 29
2025
Q3
$3.45M Sell
23,610
-1,178
-5% -$178K 1.59% 14
2025
Q2
$3.87M Buy
24,788
+170
+0.7% +$27K 1.84% 10
2025
Q1
$4.05M Sell
24,618
-325
-1% -$54K 2.06% 10
2024
Q4
$4.06M Buy
24,943
+1,775
+8% +$317K 2.07% 7
2024
Q3
$4.53M Hold
23,168
2.12% 7
2024
Q2
$4.02M Sell
23,168
-1,925
-8% -$320K 1.93% 7
2024
Q1
$4.25M Buy
25,093
+1,525
+6% +$286K 2.08% 8
2023
Q4
$4.65M Buy
23,568
+1,340
+6% +$237K 2.46% 6
2023
Q3
$3.87M Buy
22,228
+3,975
+22% +$722K 2.2% 6
2023
Q2
$3.14M Buy
18,253
+1,150
+7% +$199K 1.82% 13
2023
Q1
$2.85M Buy
17,103
+200
+1% +$32.8K 1.67% 14
2022
Q4
$2.48M Sell
16,903
-300
-2% -$44.4K 1.42% 18
2022
Q3
$2.55M Buy
17,203
+1,200
+7% +$201K 1.61% 14
2022
Q2
$2.75M Sell
16,003
-120
-0.7% -$20.8K 1.6% 11
2022
Q1
$3.04M Sell
16,123
-175
-1% -$34.6K 1.58% 14
2021
Q4
$3.98M Sell
16,298
-244
-1% -$53.4K 1.92% 8
2021
Q3
$3.21M Sell
16,542
-26
-0.2% -$5.25K 1.68% 10
2021
Q2
$3.09M Sell
16,568
-7
-0% -$1.22K 1.6% 11
2021
Q1
$2.61M Sell
16,575
-71
-0.4% -$11.2K 1.43% 15
2020
Q4
$2.75M Sell
16,646
-377
-2% -$61.3K 1.7% 12
2020
Q3
$2.81M Sell
17,023
-175
-1% -$26.9K 2.04% 9
2020
Q2
$2.36M Sell
17,198
-450
-3% -$58.8K 1.69% 11
2020
Q1
$2.08M Buy
17,648
+175
+1% +$23K 1.77% 14
2019
Q4
$2.31M Sell
17,473
-100
-0.6% -$12.4K 1.55% 11
2019
Q3
$2.19M Sell
17,573
-500
-3% -$60.4K 1.59% 10
2019
Q2
$2.05M Hold
18,073
1.39% 13
2019
Q1
$1.82M Sell
18,073
-450
-2% -$40.9K 1.23% 18
2018
Q4
$1.58M Sell
18,523
-900
-5% -$81.1K 1.25% 18
2018
Q3
$1.78M Sell
19,423
-150
-0.8% -$13.3K 1.16% 20
2018
Q2
$1.67M Sell
19,573
-425
-2% -$35.9K 1.1% 20
2018
Q1
$1.67M Sell
19,998
-325
-2% -$25.6K 1.12% 19
2017
Q4
$1.46M Sell
20,323
-10,095
-33% -$693K 1.05% 27
2017
Q3
$1.94M Buy
30,418
+900
+3% +$56.4K 1.42% 12
2017
Q2
$1.84M Buy
29,518
+250
+0.9% +$14.8K 1.36% 13
2017
Q1
$1.56M Buy
29,268
+10,523
+56% +$569K 1.2% 18
2016
Q4
$1M Buy
18,745
+5,550
+42% +$282K 0.79% 36
2016
Q3
$686K Buy
13,195
+2,350
+22% +$119K 0.58% 62
2016
Q2
$515K Sell
10,845
-10,400
-49% -$491K 0.44% 76
2016
Q1
$942K Buy
21,245
+425
+2% +$18K 0.8% 39
2015
Q4
$998K Sell
20,820
-4,200
-17% -$190K 0.86% 31
2015
Q3
$1.03M Buy
25,020
+14,420
+136% +$669K 0.98% 21
2015
Q2
$511K Buy
10,600
+800
+8% +$38.2K 0.42% 93
2015
Q1
$454K Buy
+9,800
New +$442K 0.39% 99
2014
Q4
Sell
-5,450
Closed -$201K 191
2014
Q3
$201K Sell
5,450
-14,075
-72% -$482K 0.18% 159
2014
Q2
$630K Buy
19,525
+950
+5% +$29.1K 0.56% 76
2014
Q1
$538K Buy
18,575
+2,275
+14% +$69.5K 0.49% 88
2013
Q4
$533K Buy
+16,300
New +$520K 0.51% 76

Other funds holding ZTS

New England Research & Management's ZTS Position: Q2 2026 in Review

New England Research & Management reduced its Zoetis (ZTS) stake by 9.5% in Q2 2026, selling an estimated $182K and leaving 18,461 shares worth $1.33M. The position accounts for 0.52% of the portfolio, ranked #62.

New England Research & Management first reported a position in ZTS in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.65M in Q4 2023. 274 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • New England Research & Management held 18,461 shares of Zoetis worth $1.33M as of Q2 2026.
  • New England Research & Management sold 1,930 Zoetis shares in Q2 2026, an estimated $182K.
  • Zoetis made up 0.52% of New England Research & Management's portfolio in Q2 2026, its #62 holding.
  • New England Research & Management first reported a position in Zoetis in Q4 2013 and has held it in 50 quarters since.
  • New England Research & Management's Zoetis position peaked at $4.65M in Q4 2023.
  • 274 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.